Close

Knowledge Bank

Improving Antibiotic Use And Testing To Combat SSIs And MDR

According to recent research, hospitals in the Global South must use more targeted antibiotics and conduct appropriate testing for surgical site infections (SSI) in order to help stop the development of antimicrobial resistance (AMR). Researchers examined procedures at fifty-four hospitals...

Re-evaluating Airborne Illness Control And MRSA Prevention

In the summer of 2024, scientific research and news articles abound about the growing danger posed by deadly illnesses. The public's interest in these outbreaks has generally been low, and the government's reaction to the risks they represent has...

Hospital Patients Increase MRSA Risk For Family Members

A recent study that was conducted by the Society for Healthcare Epidemiology of America and published in the journal Infection Control & Hospital Epidemiology suggests that family members of patients who have been discharged from hospitals may be at...

Hospital Hygiene Trends: Enhancing Patient Care And Safety

Hygiene in hospitals is more than just a habit; it is an essential component of both the safety of patients and the quality of treatment they get. Maintaining high levels of hygiene is vital for avoiding infections and establishing...

Smart Hospitals: Revolutionizing Patient Safety With AI

Smart hospitals are transforming healthcare surroundings with innovative techniques such as predictive analytics and cutting-edge cleaning procedures. Smart hospitals use cutting edge technology to improve patient care and operational effectiveness, revolutionizing the delivery of healthcare. These developments use smart technology to...

Strengthening Infection Control: Mauritius New IPC Plan

Infection Prevention and Control (IPC), which refers to the evidence-based strategy to safeguarding patients and healthcare workers from illnesses that can be avoided, is commonly acknowledged as one of the fundamental components of a health care delivery system that...

Genprex Announces Plans to Launch Separate Company to Focus on the Development of Gene Therapy to Treat Type-1 and Type-2 Diabetes

Genprex, Inc. a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes announced its intention to transfer the Company's diabetes clinical development program and its diabetes gene therapy assets into a new, wholly-owned...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read